Skip to main content

Table 2 Baseline characteristics, past medical history and preoperative medication

From: A novel treatment strategy of new onset atrial fibrillation after cardiac surgery: an observational prospective study

 

All

Converted n = 14

Non-converted n = 9

p-value

Age

69.63 ± 6.34

68.21 ± 7.21

71.22 ± 4.58

0.279

CVA (%)

13

21.4

0

0.253

COPD (%)

13

14.3

11.1

1.000

Diabetis mellitus (%)

17.4

14.3

22.2

1.000

Female (%)

26.1

21.4

33.3

0.643

Height (cm)

172.71 ± 8.33

172.64 ± 8.28

172 ± 9

0.862

Hyperlipidemia (%)

43.5

42.9

44.4

1.000

Hypertension (%)

78.3

78.6

77.8

1.000

PAD (%)

8.7

7.1

11.1

1.000

Renal insufficiency or creatinin >1.1 (%)

8.7

7.1

11.1

1.000

Smoker (%)

21.7

28.6

11.1

0.611

Weight (kg)

80.56 ± 13.17

81.24 ± 14.26

79.33 ± 12.87

0.748

ACE-inhibitors(%)

36.4

23.1

55.6

0.187

Aspirin (%)

86.4

84.6

88.9

1.000

Beta-blockers (%)

72.7

69.2

77.8

1.000

Ca-antagonist (%)

36.4

30.8

44.4

0.662

Clopidogrel (%)

4.5

7.7

0

1.000

Cortison (%)

4.5

7.7

0

1.000

Diuretics (%)

31.8

38.5

22.2

0.648

Statin (%)

63.6

69.2

55.6

1.000

  1. COPD: chronic obstructive pulmonary disease,CVA: cerebrovascular accident, PAD: peripheral arterial disease.